RxDoctor Payments Data

Emily Williams, MD

Family Medicine · Jasper, ALNPI 1659593655

Payments from drug & device makers

$11,486in general payments, 2019–2025

Across 720 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • AbbVie$1K
  • GSK$1K
  • Lilly USA, LLC$1K
  • Pfizer$775
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$11,456100%
  • Education$300%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,486 in reported general payments places this provider in the 90th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$114,846
Medicare patients
252
Services billed
4,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban191$157,402
JanuviaSitagliptin Phosphate143$123,451
OzempicSemaglutide125$121,340
MounjaroTirzepatide91$111,004
Tresiba Flextouch U-200Insulin Degludec76$80,083
Trelegy ElliptaFluticasone/Umeclidin/Vilanter80$76,261
JardianceEmpagliflozin65$67,194
FarxigaDapagliflozin Propanediol67$53,445
XareltoRivaroxaban47$46,409
LinzessLinaclotide48$35,921
Humalog Kwikpen U-200Insulin Lispro15$30,764
TrulicityDulaglutide25$24,984
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$21,420
Breo ElliptaFluticasone/Vilanterol39$20,092
Tresiba Flextouch U-100Insulin Degludec37$19,117

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$775$157,402191 claims
Lilly USA, LLCMounjaro, Trulicity$1,097$135,988116 claims
MerckJanuvia, Lagevrio (Eua)$146$130,779154 claims
Novo NordiskOzempic$1,543$121,340125 claims
GSKTrelegy Ellipta, Breo Ellipta$1,240$96,353119 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$305$88,866101 claims
AstraZenecaFarxiga, Symbicort$1,550$60,16088 claims
AbbVieLinzess, Synthroid, Savella$1,369$51,191161 claims
Johnson & JohnsonXarelto$656$46,40947 claims
Astellas Pharma US IncMyrbetriq$68$16,38530 claims
NovartisEntresto$98$4,30812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Jasper

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →